Tema Oncology ETF (CANC) Holdings $23.50 -0.45 (-1.90%) As of 04/3/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Top 53 CANC HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$788.62-3.6%5.26%4,2102RHHBYRoche$40.02+1.7%5.20%80,4003RVMDRevolution Medicines$32.87-5.0%5.07%87,6444AstraZeneca PLCN/A4.43%19,3575BMYBristol-Myers Squibb$57.71-3.2%4.43%49,3616Novartis AGN/A4.04%24,1577EXELExelixis$36.68-1.0%3.96%71,4968NUVLNuvalent$68.32-3.0%3.91%33,7949BBIOBridgeBio Pharma$34.07-1.6%3.88%76,96610MRUSMerus$41.73-3.0%3.20%45,558 Get the Latest News and Ratings for CANC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. 11ONCBeigene$264.32-3.8%3.12%7,84012GMABGenmab A/S$19.24+2.2%3.11%102,74913Chugai Pharmaceutical Co., Ltd.N/A3.04%44,99614ACLXArcellx$62.44-7.1%3.03%28,45015LEGNLegend Biotech$32.88-1.1%2.96%52,00816MRKMerck & Co., Inc.$86.32-0.3%2.96%21,12317SMMTSummit Therapeutics$18.91-7.6%2.95%98,11118AMGNAmgen$309.85+1.4%2.91%6,16319Daiichi Sankyo Company, LimitedN/A2.91%80,80220BPMCBlueprint Medicines$87.11-3.2%2.83%20,97221JANXJanux Therapeutics$26.99-4.5%2.12%45,93722ABBVAbbVie$201.31-1.9%2.10%6,61323ZLABZai Lab$36.69+0.7%2.01%35,40224ARGXargenx$590.06+1.1%1.88%2,03225GILDGilead Sciences$112.39+0.4%1.76%10,96426IDYAIDEAYA Biosciences$15.57-4.8%1.29%47,37127REGNRegeneron Pharmaceuticals$610.64-2.4%1.10%1,09228MREOMereo BioPharma Group$2.21-6.8%1.02%263,66329DAWNDay One Biopharmaceuticals$7.71-3.3%0.99%79,81830CGONCG Oncology$18.74-15.7%0.94%22,47031NRIXNurix Therapeutics$10.51-7.6%0.92%44,23832COGTCogent Biosciences$5.33-6.8%0.79%71,56333GHGuardant Health$42.02-3.4%0.70%10,16034INCYIncyte$62.46+0.2%0.70%7,75035LNTHLantheus$97.21-0.2%0.67%4,32936IMCRImmunocore$29.04-1.3%0.66%15,42837REPLReplimune Group$7.89-8.5%0.64%37,52238ZYMEZymeworks$11.75-1.4%0.63%33,00139EXASExact Sciences$44.28-0.6%0.57%8,42040SDGRSchrödinger$18.87-5.1%0.56%16,457Collect $7k per month from Tesla’s SECRET dividend (Ad)Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…Click here to discover the new #1 way to invest in Tesla41CGEMCullinan Therapeutics$7.49-4.2%0.51%39,16442ELVNEnliven Therapeutics$20.03+0.9%0.49%15,73443ARVNArvinas$6.90-3.9%0.47%36,24144ORICORIC Pharmaceuticals$5.26-9.0%0.46%40,93445ILMNIllumina$76.42-6.7%0.45%3,51346RLAYRelay Therapeutics$2.29-8.0%0.44%89,11047SNDXSyndax Pharmaceuticals$12.46-3.9%0.41%21,16948First American Treasury Obligations FundN/A0.38%251,68949AUTLAutolus Therapeutics$1.51-3.8%0.32%110,42850IOVAIovance Biotherapeutics$3.25-8.2%0.27%50,15951CELCCelcuity$8.85-5.4%0.25%15,61952RCUSArcus Biosciences$7.16-9.3%0.21%15,25153DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A0.15%588,156,276 Related Companies and Tools Related Companies Fidelity Disruptive Communications ETF Portfolio Companies Tradr 2X Long Innovation ETF Portfolio Companies Tema Electrification ETF Portfolio Companies RockCreek Global Equality ETF Portfolio Companies Tema Cardiovascular and Metabolics ETF Portfolio Companies Global X Data Center & Digital Infrastructure ETF Portfolio Companies Invesco ESG NASDAQ 100 ETF Portfolio Companies VictoryShares THB Mid Cap ESG ETF Portfolio Companies Global X Aging Population ETF Portfolio Companies Global X E-Commerce ETF Portfolio Companies This page (NASDAQ:CANC) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow you could profit from Elon’s latest AI breakthroughEvery single one of Elon's projects minted an entire new class of millionaires. And xAI could be next in li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
